Skip to main content
OpenTrials
Completed

NCT Number: NCT07364435

Effect of Bed Bathing Methods on VRE Colonization in ICU Patients

This randomized controlled trial aims to compare the effects of two different bed bathing methods on vancomycin-resistant Enterococcus (VRE) colonization in adult intensive care unit patients. A total of 210 patients were randomly assigned to receive either daily whole-body bathing with 4% chlorhexidine gluconate solution or daily bed bathing using disposable antibacterial body wipes. VRE colonization was monitored using skin swab cultures collected on days 7, 14, and 21. The results of this study may contribute to infection prevention strategies in intensive care units by identifying effective hygiene practices for reducing VRE colonization.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Basaksehir Pine and Sakura City Hospital

Istanbul, 34000, Turkey (Türkiye)

About this study

This study was designed as a randomized controlled trial conducted in the general intensive care units of a tertiary care hospital. Adult patients meeting the inclusion criteria were randomly assigned to one of two parallel groups. The experimental group received daily whole-body bed bathing with a 4% chlorhexidine gluconate solution, while the control group received daily bed bathing using disposable antibacterial body cleansing wipes.

Randomization was performed to ensure comparable baseline characteristics between the groups. VRE colonization was assessed through skin swab cultures obtained at baseline and subsequently on days 7, 14, and 21. The primary outcome of the study was the rate of VRE colonization over time. Secondary analyses included the evaluation of patient-related factors such as age, length of stay, body mass index, and previous VRE history.

All procedures were performed by trained nursing staff according to standardized protocols. The study was conducted following ethical approval obtained from the institutional ethics committee, and informed consent was obtained in accordance with ethical standards. The findings of this study aim to support evidence-based infection control practices in intensive care nursing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged 18 years and older
  • Patients admitted to the intensive care unit
  • Expected ICU stay of at least 48 hours
  • Patients requiring daily bed bathing

Exclusion criteria

  • Known hypersensitivity to chlorhexidine
  • Extensive skin lesions or burns
  • Patients colonized or infected with VRE at ICU admission
  • Pregnancy

Treatment and study plan

Bed Bath

Procedure

Daily whole-body bed bathing performed as part of routine ICU care.

Other names: Daily whole-body bathing with 4% chlorhexidine gluconate solution.

Disposable antibacterial bed bath wipes

Device

Daily whole-body bed bathing using disposable antibacterial body cleansing wipes as part of routine ICU care.

Other names: Daily bed bathing using disposable antibacterial body cleansing wipes., Antibacterial bathing wipes

Chlorhexidine gluconate 4%

Drug

A 4% chlorhexidine gluconate solution used during the bed bathing procedure for whole-body skin antisepsis in ICU patients.

Other names: CHG 4% solution

Primary outcomes

  1. Vancomycin-Resistant Enterococcus (VRE) Colonization

    Time frame: Baseline, Day 7, Day 14, and Day 21

    The presence of vancomycin-resistant Enterococcus (VRE) colonization assessed by skin swab cultures obtained from intensive care unit patients. Cultures were collected at baseline and on days 7, 14, and 21 to compare the effect of two different bed bathing methods.

Sponsors and collaborators

Lead sponsor

Özkan Kasap

Other Gov

Registry information

Official study title

The Effect of Two Different Bed Bathing Methods on Vancomycin-Resistant Enterococcus Colonization in Intensive Care Patients: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 23, 2026
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.